USANA Health Sciences announced that its omega-3 supplement, BiOmega, was granted approval by ConsumerLab.com, which is an independent tester of health and wellness products. The cellular...
The euro continues to make inroads and is in positive territory for a third successive week. Currently, EUR/USD is trading at 1.2287, up 0.31% on the...
Regeneron Pharmaceuticals revealed encouraging initial data from its ongoing Phase 1/2/3 clinical trial of its antibody cocktail (casirivimab and imdevimab) in hospitalized COVID-19 patients on low-flow...
Pharmaceutical scientist sees potential problems with remdesivir as a COVID-19 treatment Credit: University of Cincinnati While the world has its eyes on vaccines to stop the...
Shares of Hepion Pharmaceuticals exploded 47% in Wednesday’s pre-market trading after the biopharma company released “positive” top line trial results for its oral inhibitor used in...
Pompeo Demands "Lying" China Release Wuhan Citizen Journalist Locked Up For Virus Reporting US Secretary of State Mike is demanding that China immediately release a citizen journalist...
2020, a year dominated by COVID-19 and government-mandated lockdowns, saw Tech Oligarchs Facebook and Twitter profiting, both monetarily and politically, from their stranglehold on information. Parler...
US Troops In S.Korea First To Receive Mass Vaccination As Host Country Cases Soar The first large-scale Pentagon vaccination effort of US troops stationed abroad is...
A federal appeals court upheld a White House-backed rule to require hospitals to disclose the prices they negotiate with insurers for an array of common tests...
Observational clinical research of COVID-19 patients can help clinicians better understand how the previously unknown SARS-CoV-2 virus acts, and findings from this research can better inform...
As Arcturus Therapeutics charges full speed into a Phase II trial for its single-dose Covid-19 vaccine in Singapore, some analysts say weak Phase I/II data point...
RBC Capital downgraded Aprea Therapeutics to Hold from Buy as the biopharma company said Monday that its Phase 3 trial of Eprenetapopt molecule in TP53 Mutant...
Shares of Myovant Sciences surged 20.5% after the biopharma company announced a collaboration with Pfizer (PFE) to jointly develop and commercialize ORGOVYX – a drug for...
Are We Really Going To 'Build Back Better' After A "Dark Winter"? Authored by Jim Quinn via The Burning Platform blog, “It’s like in the great...
The United Kingdom, which was the first to grant authorization to the vaccine developed by Pfizer and Moderna, is expected to give the green light to...
AstraZeneca and MSD’s (Merck (MRK) is known as MSD outside the US and Canada) Lynparza (olaparib) has been approved in Japan for the treatment of three...
United Therapeutics Corporation has announced that it has agreed to buy a Priority Review Voucher (PRV) for $105 million, which it plans to use with an...
The New COVID-19 Strain Is A Political Disaster Of Our Own Making Authored by Rob Sutton via TheCritic.co.uk, By seeking answers to scientific questions no-one...
L.A. County Is Running "Dangerously" Low On Oxygen To Treat COVID-19 Hospitals in L.A. Country are starting to run "dangerously low on oxygen" and other supplies...
Scientists Scramble To Identify Culprit Behind Covid Vaccine Allergic Reactions All is not going according to plan in the global rollout of what is arguably the...
Did Fauci Just Admit He Lied About Herd Immunity To Trick Americans Into Vaccine? Dr. Anthony Fauci, the Democrat-approved 'science' in 'trust the science,' appears to...
A resurgence of coronavirus cases in several countries and a new COVID-19 variant identified in the UK are boosting fears over a slew of lockdown and...
Take a deep breath, get ready, the New Year is just around the corner, and while we’re all ready to celebrate – just on principle, because...
Report on T cell immunity to SARS-CoV-2 in the Japanese population Credit: Sysmex/Kobe University Kobe University (Location: Kobe, Japan; President: Hiroshi Takeda) and Sysmex Corporation (HQ:...
As vaccination begins to take effect, what we'll be able to do will change – but the transformation will be slow.
As vaccination begins to take effect, what we'll be able to do will change – but the transformation will be slow.
I Had COVID For 17 Days, Here's What It Was Like Authored by Daisy Luther via The Organic Prepper blog, A lot of folks are out...
Insiders are an interesting lot. From an investor’s perspective, corporate officers have access to information – and information has always been the key to successful investing.
Shares of Voyager Therapeutics were down more than 10 percent in trading on Dec. 23 after the company announced the U.S. Food and Drug Administration placed a clinical...
Credit: University of Gothenburg. Immunizing children against chickenpox would save money, but offering shingles vaccinations to all 65-year-olds would not. These are examples of findings in...